2m1x: Difference between revisions

No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
==TICAM-1 TIR domain structure==
==TICAM-1 TIR domain structure==
<StructureSection load='2m1x' size='340' side='right' caption='[[2m1x]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
<StructureSection load='2m1x' size='340' side='right'caption='[[2m1x]]' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[2m1x]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2M1X OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2M1X FirstGlance]. <br>
<table><tr><td colspan='2'>[[2m1x]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2M1X OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2M1X FirstGlance]. <br>
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2m1w|2m1w]]</td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TICAM1, PRVTIRB, TRIF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2m1x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2m1x OCA], [https://pdbe.org/2m1x PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2m1x RCSB], [https://www.ebi.ac.uk/pdbsum/2m1x PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2m1x ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2m1x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2m1x OCA], [http://pdbe.org/2m1x PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2m1x RCSB], [http://www.ebi.ac.uk/pdbsum/2m1x PDBsum]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/TCAM1_HUMAN TCAM1_HUMAN]] Herpetic encephalitis. Herpes simplex encephalitis 4 (HSE4) [MIM:[http://omim.org/entry/614850 614850]]: A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. HSE is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.<ref>PMID:22105173</ref>
[https://www.uniprot.org/uniprot/TCAM1_HUMAN TCAM1_HUMAN] Herpetic encephalitis. Herpes simplex encephalitis 4 (HSE4) [MIM:[https://omim.org/entry/614850 614850]: A rare complication of human herpesvirus 1 (HHV-1) infection, occurring in only a small minority of HHV-1 infected individuals. HSE is characterized by hemorrhagic necrosis of parts of the temporal and frontal lobes. Onset is over several days and involves fever, headache, seizures, stupor, and often coma, frequently with a fatal outcome. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.<ref>PMID:22105173</ref>  
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/TCAM1_HUMAN TCAM1_HUMAN]] Involved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.<ref>PMID:12471095</ref> <ref>PMID:12539043</ref> <ref>PMID:14739303</ref>
[https://www.uniprot.org/uniprot/TCAM1_HUMAN TCAM1_HUMAN] Involved in innate immunity against invading pathogens. Adapter used by TLR3 and TLR4 (through TICAM2) to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis. Ligand binding to these receptors results in TRIF recruitment through its TIR domain. Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively.<ref>PMID:12471095</ref> <ref>PMID:12539043</ref> <ref>PMID:14739303</ref>  
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 20: Line 20:
</div>
</div>
<div class="pdbe-citations 2m1x" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 2m1x" style="background-color:#fffaf0;"></div>
==See Also==
*[[TIR domain-containing adapter protein|TIR domain-containing adapter protein]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Enokizono, Y]]
[[Category: Large Structures]]
[[Category: Funami, K]]
[[Category: Enokizono Y]]
[[Category: Horiuchi, M]]
[[Category: Funami K]]
[[Category: Inagaki, F]]
[[Category: Horiuchi M]]
[[Category: Kumeta, H]]
[[Category: Inagaki F]]
[[Category: Matsumoto, M]]
[[Category: Kumeta H]]
[[Category: Sarmiento, J]]
[[Category: Matsumoto M]]
[[Category: Seya, T]]
[[Category: Sarmiento J]]
[[Category: Standley, D M]]
[[Category: Seya T]]
[[Category: Yamashita, K]]
[[Category: Standley DM]]
[[Category: Immune system]]
[[Category: Yamashita K]]
[[Category: Innate immunity]]
[[Category: Interferon]]
[[Category: Ticam-1]]
[[Category: Tir domain]]
[[Category: Trif]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA